Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Variant classification in precision oncology.

Leichsenring J, Horak P, Kreutzfeldt S, Heining C, Christopoulos P, Volckmar AL, Neumann O, Kirchner M, Ploeger C, Budczies J, Heilig CE, Hutter B, Fröhlich M, Uhrig S, Kazdal D, Allgäuer M, Harms A, Rempel E, Lehmann U, Thomas M, Pfarr N, Azoitei N, Bonzheim I, Marienfeld R, Möller P, Werner M, Fend F, Boerries M, von Bubnoff N, Lassmann S, Longerich T, Bitzer M, Seufferlein T, Malek N, Weichert W, Schirmacher P, Penzel R, Endris V, Brors B, Klauschen F, Glimm H, Fröhling S, Stenzinger A.

Int J Cancer. 2019 Apr 22. doi: 10.1002/ijc.32358. [Epub ahead of print]

PMID:
31008532
2.

[Volume perfusion computed tomography: Applications in the liver].

Spogis J, Bitzer M, Horger M.

Rofo. 2019 Apr 11. doi: 10.1055/a-0881-3346. [Epub ahead of print] German. No abstract available.

PMID:
30974476
3.

The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research.

Das S; Extracellular RNA Communication Consortium, Ansel KM, Bitzer M, Breakefield XO, Charest A, Galas DJ, Gerstein MB, Gupta M, Milosavljevic A, McManus MT, Patel T, Raffai RL, Rozowsky J, Roth ME, Saugstad JA, Van Keuren-Jensen K, Weaver AM, Laurent LC.

Cell. 2019 Apr 4;177(2):231-242. doi: 10.1016/j.cell.2019.03.023. Review.

PMID:
30951667
4.

Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?

Ruff C, Grözinger G, Syha R, Elser S, Partovi S, Bitzer M, Horger M, Nikolaou K, Grosse U.

J Vasc Interv Radiol. 2019 Mar;30(3):380-389.e4. doi: 10.1016/j.jvir.2018.09.001.

PMID:
30819480
5.

[Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment].

Reinmuth N, Bitzer M, Deschler-Baier B, Fischer JR, Kuon J, Leipe J, Rawluk J, Schulz C, Heußel CP, Schultheiß M.

Dtsch Med Wochenschr. 2019 Mar;144(5):346-353. doi: 10.1055/a-0739-8194. Epub 2019 Jan 30. German.

PMID:
30699440
6.

Organoid single cell profiling identifies a transcriptional signature of glomerular disease.

Harder JL, Menon R, Otto EA, Zhou J, Eddy S, Wys NL, O'Connor C, Luo J, Nair V, Cebrian C, Spence JR, Bitzer M, Troyanskaya OG, Hodgin JB, Wiggins RC, Freedman BS, Kretzler M; European Renal cDNA Bank (ERCB); Nephrotic Syndrome Study Network (NEPTUNE).

JCI Insight. 2019 Jan 10;4(1). pii: 122697. doi: 10.1172/jci.insight.122697. [Epub ahead of print]

7.

Cationic abnormal N-heterocyclic carbene ruthenium complexes as suitable precursors for the synthesis of heterobimetallic compounds.

Pardatscher L, Bitzer MJ, Jandl C, Kück JW, Reich RM, Kühn FE, Baratta W.

Dalton Trans. 2018 Dec 18;48(1):79-89. doi: 10.1039/c8dt03713b.

PMID:
30456401
8.

Correlation between acoustic radiation force impulse (ARFI)-based tissue elasticity measurements and perfusion parameters acquired by perfusion CT in cirrhotic livers: a proof of principle.

Esser M, Bitzer M, Kolb M, Fritz J, Kurucay M, Ruff C, Horger M.

J Med Ultrason (2001). 2019 Jan;46(1):81-88. doi: 10.1007/s10396-018-0886-x. Epub 2018 Jun 13.

PMID:
29948475
9.

Paradigm Shift in the Management of Irresectable Colorectal Liver Metastases: Living Donor Auxiliary Partial Orthotopic Liver Transplantation in Combination With Two-stage Hepatectomy (LD-RAPID).

Königsrainer A, Templin S, Capobianco I, Königsrainer I, Bitzer M, Zender L, Sipos B, Kanz L, Wagner S, Nadalin S.

Ann Surg. 2018 Jun 18. doi: 10.1097/SLA.0000000000002861. [Epub ahead of print]

PMID:
29916882
10.

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.

Heining C, Horak P, Uhrig S, Codo PL, Klink B, Hutter B, Fröhlich M, Bonekamp D, Richter D, Steiger K, Penzel R, Endris V, Ehrenberg KR, Frank S, Kleinheinz K, Toprak UH, Schlesner M, Mandal R, Schulz L, Lambertz H, Fetscher S, Bitzer M, Malek NP, Horger M, Giese NA, Strobel O, Hackert T, Springfeld C, Feuerbach L, Bergmann F, Schröck E, von Kalle C, Weichert W, Scholl C, Ball CR, Stenzinger A, Brors B, Fröhling S, Glimm H.

Cancer Discov. 2018 Sep;8(9):1087-1095. doi: 10.1158/2159-8290.CD-18-0036. Epub 2018 May 25.

PMID:
29802158
11.

Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis.

Lauer UM, Schell M, Beil J, Berchtold S, Koppenhöfer U, Glatzle J, Königsrainer A, Möhle R, Nann D, Fend F, Pfannenberg C, Bitzer M, Malek NP.

Clin Cancer Res. 2018 Sep 15;24(18):4388-4398. doi: 10.1158/1078-0432.CCR-18-0244. Epub 2018 May 17.

PMID:
29773661
12.

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).

Ruhstaller T, Thuss-Patience P, Hayoz S, Schacher S, Knorrenschild JR, Schnider A, Plasswilm L, Budach W, Eisterer W, Hawle H, Mariette C, Hess V, Mingrone W, Montemurro M, Girschikofsky M, Schmidt SC, Bitzer M, Bedenne L, Brauchli P, Stahl M; Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft Medikamentöse Tumortherapie’ (AGMT), and the Fédération Francophone de Cancérologie Digestive (FFCD)/Fédération de Recherche en Ch.

Ann Oncol. 2018 Jun 1;29(6):1386-1393. doi: 10.1093/annonc/mdy105.

PMID:
29635438
13.

Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.

Taron J, Johannink J, Bitzer M, Nikolaou K, Notohamiprodjo M, Hoffmann R.

Cancer Imaging. 2018 Mar 7;18(1):10. doi: 10.1186/s40644-018-0140-1.

14.

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

Vogel A, Kasper S, Bitzer M, Block A, Sinn M, Schulze-Bergkamen H, Moehler M, Pfarr N, Endris V, Goeppert B, Merx K, Schnoy E, Siveke JT, Michl P, Waldschmidt D, Kuhlmann J, Geissler M, Kahl C, Evenkamp R, Schmidt T, Kuhlmann A, Weichert W, Kubicka S.

Eur J Cancer. 2018 Mar;92:11-19. doi: 10.1016/j.ejca.2017.12.028. Epub 2018 Feb 3.

PMID:
29413685
15.

Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.

Frey N, Venturelli S, Zender L, Bitzer M.

Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):81-95. doi: 10.1038/nrgastro.2017.146. Epub 2017 Nov 29. Review.

PMID:
29184185
16.

Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.

Bailey DL, Pichler BJ, Gückel B, Antoch G, Barthel H, Bhujwalla ZM, Biskup S, Biswal S, Bitzer M, Boellaard R, Braren RF, Brendle C, Brindle K, Chiti A, la Fougère C, Gillies R, Goh V, Goyen M, Hacker M, Heukamp L, Knudsen GM, Krackhardt AM, Law I, Morris JC, Nikolaou K, Nuyts J, Ordonez AA, Pantel K, Quick HH, Riklund K, Sabri O, Sattler B, Troost EGC, Zaiss M, Zender L, Beyer T.

Mol Imaging Biol. 2018 Feb;20(1):4-20. doi: 10.1007/s11307-017-1123-5.

17.

Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up.

Kaufmann S, Thaiss WM, Schulze M, Bitzer M, Lauer U, Nikolaou K, Horger M.

Acta Radiol. 2018 Jul;59(7):765-772. doi: 10.1177/0284185117732805. Epub 2017 Sep 19.

PMID:
28927298
18.

[Differentials of Benign, Multilocular, Non-Infectious Liver Lesions: An Imaging Approach].

Reinert CP, Albtoush OM, Bitzer M, Horger M, Ioanoviciu SD.

Rofo. 2017 Oct;189(10):921-926. doi: 10.1055/s-0043-113134. Epub 2017 Sep 14. German. No abstract available.

PMID:
28910833
19.

FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.

Nishizono R, Kikuchi M, Wang SQ, Chowdhury M, Nair V, Hartman J, Fukuda A, Wickman L, Hodgin JB, Bitzer M, Naik A, Wiggins J, Kretzler M, Wiggins RC.

J Am Soc Nephrol. 2017 Oct;28(10):2931-2945. doi: 10.1681/ASN.2017020174. Epub 2017 Jul 18.

20.

Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.

Stahl M, Walz MK, Riera-Knorrenschild J, Stuschke M, Sandermann A, Bitzer M, Wilke H, Budach W.

Eur J Cancer. 2017 Aug;81:183-190. doi: 10.1016/j.ejca.2017.04.027.

PMID:
28628843
21.

Future Therapy of Cholangiocarcinoma.

Plentz RR, Bitzer M, Greten T, Nadalin S, Vogel A.

Visc Med. 2016 Dec;32(6):431-433. doi: 10.1159/000450720. Epub 2016 Nov 18. No abstract available.

22.

A comprehensive quality control workflow for paired tumor-normal NGS experiments.

Schroeder CM, Hilke FJ, Löffler MW, Bitzer M, Lenz F, Sturm M.

Bioinformatics. 2017 Jun 1;33(11):1721-1722. doi: 10.1093/bioinformatics/btx032.

PMID:
28130233
23.

Reply to: "Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects".

Bitzer M, Salih HR.

J Hepatol. 2017 Apr;66(4):867-868. doi: 10.1016/j.jhep.2016.12.027. Epub 2017 Jan 9. No abstract available.

PMID:
28082146
24.

Q Fever Pneumonia in Southwest Germany: Radiographic and Clinical Findings.

Biecker A, Bitzer M, Biecker E.

Rofo. 2017 Feb;189(2):146-151. doi: 10.1055/s-0042-121610. Epub 2016 Dec 21.

25.

Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.

Hahm E, Wei C, Fernandez I, Li J, Tardi NJ, Tracy M, Wadhwani S, Cao Y, Peev V, Zloza A, Lusciks J, Hayek SS, O'Connor C, Bitzer M, Gupta V, Sever S, Sykes DB, Scadden DT, Reiser J.

Nat Med. 2017 Jan;23(1):100-106. doi: 10.1038/nm.4242. Epub 2016 Dec 12.

26.

Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.

Lee HW, Khan SQ, Khaliqdina S, Altintas MM, Grahammer F, Zhao JL, Koh KH, Tardi NJ, Faridi MH, Geraghty T, Cimbaluk DJ, Susztak K, Moita LF, Baltimore D, Tharaux PL, Huber TB, Kretzler M, Bitzer M, Reiser J, Gupta V.

J Biol Chem. 2017 Jan 13;292(2):732-747. doi: 10.1074/jbc.M116.753822. Epub 2016 Dec 2.

27.

Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review.

Zammit AR, Katz MJ, Bitzer M, Lipton RB.

Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):357-366. Review.

28.

[Acute kidney injury in liver failure].

Werner CR, Wagner V, Sipos B, Büttner-Herold M, Amann K, Haap M, Malek NP, Bitzer M, Artunc F.

Dtsch Med Wochenschr. 2016 Oct;141(21):1559. Epub 2016 Oct 17. German.

PMID:
27750343
29.
30.

An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy.

Kato M, Wang M, Chen Z, Bhatt K, Oh HJ, Lanting L, Deshpande S, Jia Y, Lai JY, O'Connor CL, Wu Y, Hodgin JB, Nelson RG, Bitzer M, Natarajan R.

Nat Commun. 2016 Sep 30;7:12864. doi: 10.1038/ncomms12864.

31.

Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization.

Grözinger G, Bitzer M, Syha R, Ketelsen D, Nikolaou K, Lauer U, Horger M.

World J Radiol. 2016 Jul 28;8(7):683-92. doi: 10.4329/wjr.v8.i7.683.

32.

Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease.

Zammit AR, Katz MJ, Derby C, Bitzer M, Lipton RB.

Prev Med Rep. 2016 Jun 7;4:128-33. doi: 10.1016/j.pmedr.2016.06.007. eCollection 2016 Dec.

33.

Albumin: innocent bystander or culprit?

Peired AJ, Bitzer M.

Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F409-10. doi: 10.1152/ajprenal.00317.2016. Epub 2016 Jun 15. No abstract available.

34.

Quantitative podocyte parameters predict human native kidney and allograft half-lives.

Naik AS, Afshinnia F, Cibrik D, Hodgin JB, Wu F, Zhang M, Kikuchi M, Wickman L, Samaniego M, Bitzer M, Wiggins JE, Ojo A, Li Y, Wiggins RC.

JCI Insight. 2016;1(7). pii: 86943. doi: 10.1172/jci.insight.86943. Epub 2016 May 19.

35.

Controlling Coordination Geometries: Ru-Carbene Complexes with Tetra-NHC Ligands.

Hollering M, Weiss DT, Bitzer MJ, Jandl C, Kühn FE.

Inorg Chem. 2016 Jun 20;55(12):6010-7. doi: 10.1021/acs.inorgchem.6b00509. Epub 2016 May 26.

PMID:
27228356
36.

Metabolic Syndrome and Smoking Are Associated with Future Development of Advanced Chronic Kidney Disease in Older Adults.

Zammit AR, Katz MJ, Derby C, Bitzer M, Lipton RB.

Cardiorenal Med. 2016 Feb;6(2):108-15. doi: 10.1159/000441624. Epub 2015 Dec 2.

37.

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.

Bitzer M, Horger M, Giannini EG, Ganten TM, Wörns MA, Siveke JT, Dollinger MM, Gerken G, Scheulen ME, Wege H, Zagonel V, Cillo U, Trevisani F, Santoro A, Montesarchio V, Malek NP, Holzapfel J, Herz T, Ammendola AS, Pegoraro S, Hauns B, Mais A, Lauer UM, Henning SW, Hentsch B.

J Hepatol. 2016 Aug;65(2):280-8. doi: 10.1016/j.jhep.2016.02.043. Epub 2016 Mar 4.

PMID:
26952006
38.

Aging Biology in the Kidney.

Bitzer M, Wiggins J.

Adv Chronic Kidney Dis. 2016 Jan;23(1):12-8. doi: 10.1053/j.ackd.2015.11.005. Review.

PMID:
26709058
39.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

40.

Strategy and rationale for urine collection protocols employed in the NEPTUNE study.

Hogan MC, Lieske JC, Lienczewski CC, Nesbitt LL, Wickman LT, Heyer CM, Harris PC, Ward CJ, Sundsbak JL, Manganelli L, Ju W, Kopp JB, Nelson PJ, Adler SG, Reich HN, Holzmann LB, Kretzler M, Bitzer M.

BMC Nephrol. 2015 Nov 17;16:190. doi: 10.1186/s12882-015-0185-3.

41.

Plants Release Precursors of Histone Deacetylase Inhibitors to Suppress Growth of Competitors.

Venturelli S, Belz RG, Kämper A, Berger A, von Horn K, Wegner A, Böcker A, Zabulon G, Langenecker T, Kohlbacher O, Barneche F, Weigel D, Lauer UM, Bitzer M, Becker C.

Plant Cell. 2015 Nov;27(11):3175-89. doi: 10.1105/tpc.15.00585. Epub 2015 Nov 3.

42.

Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance.

Zammit AR, Katz MJ, Derby C, Bitzer M, Lipton RB.

PLoS One. 2015 Oct 2;10(10):e0139369. doi: 10.1371/journal.pone.0139369. eCollection 2015.

43.

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

Hauck L, Bitzer M, Malek N, Plentz RR.

Scand J Gastroenterol. 2016 Jan;51(1):55-9. doi: 10.3109/00365521.2015.1064994. Epub 2015 Jul 3.

PMID:
26137871
44.

Ru-Ag and Ru-Au dicarbene complexes from an abnormal carbene ruthenium system.

Bitzer MJ, Pöthig A, Jandl C, Kühn FE, Baratta W.

Dalton Trans. 2015 Jul 14;44(26):11686-9. doi: 10.1039/c5dt01914a. Epub 2015 Jun 8.

PMID:
26053614
45.

Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.

Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O'Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC.

J Am Soc Nephrol. 2015 Dec;26(12):3162-78. doi: 10.1681/ASN.2014080752. Epub 2015 Jun 2.

46.

Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment.

Zammit AR, Katz MJ, Zimmerman ME, Bitzer M, Lipton RB.

Alzheimers Dement (Amst). 2015 Jun 1;1(2):152-159.

47.

On the concept of hemilability: insights into a donor-functionalized iridium(I) NHC motif and its impact on reactivity.

Riener K, Bitzer MJ, Pöthig A, Raba A, Cokoja M, Herrmann WA, Kühn FE.

Inorg Chem. 2014 Dec 15;53(24):12767-77. doi: 10.1021/ic5016324. Epub 2014 Nov 25.

PMID:
25423584
48.

Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis.

Zammit AR, Katz MJ, Lai JY, Zimmerman ME, Bitzer M, Lipton RB.

J Gerontol A Biol Sci Med Sci. 2015 Jun;70(6):764-70. doi: 10.1093/gerona/glu185. Epub 2014 Nov 13.

49.

Analysis of second-line chemotherapies for ductal pancreatic adenocarcinoma in a German single-center cohort.

Maier-Stocker C, Bitzer M, Malek NP, Plentz RR.

Scand J Gastroenterol. 2014 Dec;49(12):1480-5. doi: 10.3109/00365521.2014.978816. Epub 2014 Nov 12.

PMID:
25390691
50.

Epigenetic impacts of ascorbate on human metastatic melanoma cells.

Venturelli S, Sinnberg TW, Berger A, Noor S, Levesque MP, Böcker A, Niessner H, Lauer UM, Bitzer M, Garbe C, Busch C.

Front Oncol. 2014 Aug 25;4:227. doi: 10.3389/fonc.2014.00227. eCollection 2014.

Supplemental Content

Loading ...
Support Center